MOH
- Status: likely_approved
🇮🇱 Leustatin in Israel
Leustatin (CLADRIBINE) regulatory status in Israel.
Marketing authorisations
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
Leustatin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Leustatin approved in Israel?
Yes. MOH has authorised it; MOH has authorised it; MOH has authorised it.
Who is the marketing authorisation holder for Leustatin in Israel?
Marketing authorisation holder not available in our data.